Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes
Wellgistics Health (NASDAQ:WGRX) has announced its preliminary inclusion in both the Russell 2000 and Russell 3000 Indexes as part of the 2025 Russell US Indexes annual reconstitution. The final inclusion is expected to take effect after market close on June 27, 2025.
The Russell 3000 Index includes the 3,000 largest U.S. companies by market cap, representing about 98% of the investable U.S. equity market. The Russell 2000 Index, a subset of the Russell 3000, focuses on the small-cap segment. These indexes are key benchmarks used by investment managers and institutional investors.
Wellgistics Health (NASDAQ:WGRX) ha annunciato la sua inclusione preliminare sia nel Russell 2000 che nel Russell 3000 Index nell'ambito della ristrutturazione annuale degli indici Russell US per il 2025. L'inclusione definitiva è prevista dopo la chiusura del mercato il 27 giugno 2025.
Il Russell 3000 Index comprende le 3.000 maggiori società statunitensi per capitalizzazione di mercato, rappresentando circa il 98% del mercato azionario investibile negli Stati Uniti. Il Russell 2000 Index, un sottoinsieme del Russell 3000, si concentra sul segmento delle small cap. Questi indici sono benchmark fondamentali utilizzati dai gestori di investimenti e dagli investitori istituzionali.
Wellgistics Health (NASDAQ:WGRX) ha anunciado su inclusión preliminar tanto en el Russell 2000 como en el Russell 3000 Index como parte de la reconstitución anual de los índices Russell US 2025. Se espera que la inclusión final entre en vigor después del cierre del mercado el 27 de junio de 2025.
El Russell 3000 Index incluye las 3,000 mayores empresas estadounidenses por capitalización de mercado, representando aproximadamente el 98% del mercado de renta variable estadounidense invertible. El Russell 2000 Index, un subconjunto del Russell 3000, se enfoca en el segmento de pequeña capitalización. Estos índices son referencias clave utilizadas por gestores de inversiones e inversores institucionales.
Wellgistics Health (NASDAQ:WGRX)는 2025년 러셀 미국 지수 연례 재구성의 일환으로 러셀 2000 및 러셀 3000 지수에 예비 포함되었음을 발표했습니다. 최종 포함은 2025년 6월 27일 시장 마감 후에 발효될 예정입니다.
러셀 3000 지수는 시가총액 기준으로 미국 내 가장 큰 3,000개 기업을 포함하며, 미국 투자 가능한 주식 시장의 약 98%를 대표합니다. 러셀 2000 지수는 러셀 3000의 하위 집합으로, 소형주 부문에 중점을 둡니다. 이 지수들은 투자 관리자와 기관 투자자들이 주요 벤치마크로 활용합니다.
Wellgistics Health (NASDAQ:WGRX) a annoncé sa pré-inclusion dans les Russell 2000 et Russell 3000 Indexes dans le cadre de la reconstitution annuelle des indices Russell US 2025. L'inclusion finale devrait prendre effet après la clôture du marché le 27 juin 2025.
Le Russell 3000 Index comprend les 3 000 plus grandes entreprises américaines par capitalisation boursière, représentant environ 98 % du marché boursier américain investissable. Le Russell 2000 Index, un sous-ensemble du Russell 3000, se concentre sur le segment des petites capitalisations. Ces indices sont des références clés utilisées par les gestionnaires d'investissements et les investisseurs institutionnels.
Wellgistics Health (NASDAQ:WGRX) hat seine vorläufige Aufnahme sowohl in den Russell 2000 als auch in den Russell 3000 Index im Rahmen der jährlichen Neubildung der Russell US Indizes 2025 bekannt gegeben. Die endgültige Aufnahme soll nach Börsenschluss am 27. Juni 2025 wirksam werden.
Der Russell 3000 Index umfasst die 3.000 größten US-Unternehmen nach Marktkapitalisierung und repräsentiert etwa 98 % des investierbaren US-Aktienmarktes. Der Russell 2000 Index, ein Teil des Russell 3000, konzentriert sich auf den Small-Cap-Bereich. Diese Indizes sind wichtige Benchmarks, die von Investmentmanagern und institutionellen Anlegern verwendet werden.
- Increased visibility in the investment community through Russell indexes inclusion
- Potential for increased institutional interest and ownership
- Recognition of company's execution capabilities and shareholder value creation
- None.
TAMPA, FLORIDA / ACCESS Newswire / May 29, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced its preliminary inclusion in the Russell 2000 and Russell 3000 Indexes, as part of the 2025 Russell US Indexes annual reconstitution. FTSE Russell released the preliminary list of additions and deletions to the Russell 2000 and Russell 3000 Indexes on Friday, May 23, with final inclusion expected to take effect following the close of the U.S. equity market on Friday, June 27, 2025.
The Russell 3000 Index encompasses the 3,000 largest U.S. companies by market capitalization, representing approximately
"Wellgistics Health's preliminary inclusion in the Russell 2000 and Russell 3000 indexes marks an important milestone in our company's journey," said Brian Norton, CEO of Wellgistics Health. "This recognition enhances our visibility among the broader investment community, supports increased institutional interest and ownership in our stock, and serves as strong validation of our team's ability to execute on our business plan and drive value to our shareholders."
About Wellgistics Health
Wellgistics Health, Inc. is a publicly traded healthcare infrastructure company redefining how medications move, are priced, and reach patients. The company operates across pharmaceutical distribution, prescription technology, and clinical fulfillment-connecting over 150 direct manufacturer contracts to a nationwide network of over 6,000 independent pharmacies.
Wellgistics Health provides real-time prescription hub services, compliance-driven logistics, and patient-first fulfillment solutions, while equipping pharmacies with integrated financial, clinical, and digital tools. Its end-to-end platform supports a broad range of therapeutic areas from specialty-lite to chronic maintenance medications by eliminating friction, accelerating reimbursements, and enabling direct, transparent connections between manufacturers, providers, pharmacies, and patients.
For more information, visit www.wellgisticshealth.com.
Forward-Looking Statements
This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans, including without limitation its plan in connection with certain financings and cryptocurrencies and outlook and actions with respect to incurring future expenses. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at www.sec.gov.
For more information, please contact:
Media Contact: media@wellgisticshealth.com
Investor Relations: investors@wellgisticshealth.com
Investor Relations Contact:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: info@skylineccg.com
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire